Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 61

1.

Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.

Ramkissoon SH, Bi WL, Schumacher SE, Ramkissoon LA, Haidar S, Knoff D, Dubuc A, Brown L, Burns M, Cryan JB, Abedalthagafi M, Kang YJ, Schultz N, Reardon DA, Lee EQ, Rinne ML, Norden AD, Nayak L, Ruland S, Doherty LM, LaFrankie DC, Horvath M, Aizer AA, Russo A, Arvold ND, Claus EB, Al-Mefty O, Johnson MD, Golby AJ, Dunn IF, Chiocca EA, Trippa L, Santagata S, Folkerth RD, Kantoff P, Rollins BJ, Lindeman NI, Wen PY, Ligon AH, Beroukhim R, Alexander BM, Ligon KL.

Neuro Oncol. 2015 Mar 9. pii: nov015. [Epub ahead of print]

PMID:
25754088
2.

Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma.

Lee EQ, Reardon DA, Schiff D, Drappatz J, Muzikansky A, Grimm SA, Norden AD, Nayak L, Beroukhim R, Rinne ML, Chi AS, Batchelor TT, Hempfling K, McCluskey C, Smith KH, Gaffey SC, Wrigley B, Ligon KL, Raizer JJ, Wen PY.

Neuro Oncol. 2015 Jan 7. pii: nou350. [Epub ahead of print]

PMID:
25572329
3.

Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.

Taylor JW, Dietrich J, Gerstner ER, Norden AD, Rinne ML, Cahill DP, Stemmer-Rachamimov A, Wen PY, Betensky RA, Giorgio DH, Snodgrass K, Randall AE, Batchelor TT, Chi AS.

J Neurooncol. 2015 Feb;121(3):557-63. doi: 10.1007/s11060-014-1667-z. Epub 2014 Nov 20.

PMID:
25411098
4.

Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas.

Norden AD, Schiff D, Ahluwalia MS, Lesser GJ, Nayak L, Lee EQ, Rinne ML, Muzikansky A, Dietrich J, Purow B, Doherty LM, LaFrankie DC, Pulverenti JR, Rifenburg JA, Ruland SF, Smith KH, Gaffey SC, McCluskey C, Ligon KL, Reardon DA, Wen PY.

J Neurooncol. 2015 Jan;121(2):297-302. doi: 10.1007/s11060-014-1631-y. Epub 2014 Oct 22.

PMID:
25338318
5.

Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab.

Rahman R, Hempfling K, Norden AD, Reardon DA, Nayak L, Rinne ML, Beroukhim R, Doherty L, Ruland S, Rai A, Rifenburg J, LaFrankie D, Alexander BM, Huang RY, Wen PY, Lee EQ.

Neuro Oncol. 2014 Nov;16(11):1523-9. doi: 10.1093/neuonc/nou118. Epub 2014 Jun 23.

PMID:
24958095
6.

Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma.

Aizer AA, Arvold ND, Catalano P, Claus EB, Golby AJ, Johnson MD, Al-Mefty O, Wen PY, Reardon DA, Lee EQ, Nayak L, Rinne ML, Beroukhim R, Weiss SE, Ramkissoon SH, Abedalthagafi M, Santagata S, Dunn IF, Alexander BM.

Neuro Oncol. 2014 Nov;16(11):1547-53. doi: 10.1093/neuonc/nou098. Epub 2014 Jun 2.

PMID:
24891451
7.

Update on bevacizumab and other angiogenesis inhibitors for brain cancer.

Rinne ML, Lee EQ, Nayak L, Norden AD, Beroukhim R, Wen PY, Reardon DA.

Expert Opin Emerg Drugs. 2013 Jun;18(2):137-53. doi: 10.1517/14728214.2013.794784. Epub 2013 May 14. Review.

PMID:
23668489
8.

Relationship between cognitive and motor performance in physically well-recovered men with traumatic brain injury.

Sarajuuri J, Pasanen M, Rinne M, Vartiainen M, Lehto T, Alaranta H.

J Rehabil Med. 2013 Jan;45(1):38-46. doi: 10.2340/16501977-1060.

9.

Promoting walking among office employees - evaluation of a randomized controlled intervention with pedometers and e-mail messages.

Aittasalo M, Rinne M, Pasanen M, Kukkonen-Harjula K, Vasankari T.

BMC Public Health. 2012 Jun 6;12:403. doi: 10.1186/1471-2458-12-403.

10.

Central nervous system complications of cancer therapy.

Rinne ML, Lee EQ, Wen PY.

J Support Oncol. 2012 Jul-Aug;10(4):133-41. doi: 10.1016/j.suponc.2011.11.002. Epub 2012 Apr 27. Review.

PMID:
22542045
11.

Emerging insights into the molecular and cellular basis of glioblastoma.

Dunn GP, Rinne ML, Wykosky J, Genovese G, Quayle SN, Dunn IF, Agarwalla PK, Chheda MG, Campos B, Wang A, Brennan C, Ligon KL, Furnari F, Cavenee WK, Depinho RA, Chin L, Hahn WC.

Genes Dev. 2012 Apr 15;26(8):756-84. doi: 10.1101/gad.187922.112. Review.

12.

Integration of the effects of animal and dietary factors on total dry matter intake of dairy cows fed silage-based diets.

Huhtanen P, Rinne M, Mäntysaari P, Nousiainen J.

Animal. 2011 Apr;5(5):691-702. doi: 10.1017/S1751731110002363.

PMID:
22439992
13.

Clinical problem-solving. A startling decline.

Rinne ML, McGinnis SM, Samuels MA, Katz JT, Loscalzo J.

N Engl J Med. 2012 Mar 1;366(9):836-42. doi: 10.1056/NEJMcps1104209. No abstract available.

PMID:
22375976
14.

Transmission, diagnosis, and recommendations for control of Pseudoloma neurophilia infections in laboratory zebrafish (Danio rerio) facilities.

Murray KN, Dreska M, Nasiadka A, Rinne M, Matthews JL, Carmichael C, Bauer J, Varga ZM, Westerfield M.

Comp Med. 2011 Aug;61(4):322-9. Review.

15.

Interactive medical case. A startling decline.

Vaidya A, Dolan BM, Edlow BL, Rinne ML, McGinnis SM.

N Engl J Med. 2012 Feb 9;366(6):e11. doi: 10.1056/NEJMimc1109704. No abstract available.

16.

The effect of harvesting strategy of grass silage on digestion and nutrient supply in dairy cows.

Kuoppala K, Rinne M, Ahvenjärvi S, Nousiainen J, Huhtanen P.

J Dairy Sci. 2010 Jul;93(7):3253-63. doi: 10.3168/jds.2009-3013.

PMID:
20630241
17.

Is generic physical activity or specific exercise associated with motor abilities?

Rinne M, Pasanen M, Miilunpalo S, Mälkiä E.

Med Sci Sports Exerc. 2010 Sep;42(9):1760-8. doi: 10.1249/MSS.0b013e3181d83086.

PMID:
20164811
18.

Association of physical fitness with health-related quality of life in Finnish young men.

Häkkinen A, Rinne M, Vasankari T, Santtila M, Häkkinen K, Kyröläinen H.

Health Qual Life Outcomes. 2010 Jan 29;8:15. doi: 10.1186/1477-7525-8-15.

19.

Effects of feeding grass or red clover silage cut at two maturity stages in dairy cows. 2. Dry matter intake and cell wall digestion kinetics.

Kuoppala K, Ahvenjärvi S, Rinne M, Vanhatalo A.

J Dairy Sci. 2009 Nov;92(11):5634-44. doi: 10.3168/jds.2009-2250.

PMID:
19841223
20.

Effects of feeding grass or red clover silage cut at two maturity stages in dairy cows. 1. Nitrogen metabolism and supply of amino acids.

Vanhatalo A, Kuoppala K, Ahvenjärvi S, Rinne M.

J Dairy Sci. 2009 Nov;92(11):5620-33. doi: 10.3168/jds.2009-2249.

PMID:
19841222
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk